Latest Ceo Appointment News

Future Metals NL has raised A$4.2 million and entered a strategic MOU with Zeta Resources to explore processing its Eileen Bore and Panton ores at the Savannah Mine plant, signalling a new phase of development amid rising PGM prices.

Critical Resources Limited reports significant expansion of lithium mineralisation at its Mavis Lake project and advances gold-antimony exploration in NSW, alongside appointing a new CEO and completing a $1.1 million capital raise.

Air New Zealand has appointed Chief Digital Officer Nikhil Ravishankar as its new CEO, set to take the helm in October 2025, signaling a fresh leadership era focused on innovation and resilience.

Killi Resources continues to build momentum at its Mt Rawdon West and West Tanami projects, progressing exploration and preparing for drilling while maintaining a solid cash position.

Noronex Limited reports promising new copper mineralisation from diamond drilling at its Fiesta Project and extends its strategic alliance with South32 into Botswana, alongside appointing a new CEO to spearhead growth.

Environmental Clean Technologies has announced that CEO John Tranfield will resign effective 29 October 2025, with a transition period planned to support ongoing strategic initiatives.

Holista Colltech reported steady customer receipts and a 38% surge in dietary supplement sales for 2QFY25, while progressing its high-value nano-collagen business and refreshing its leadership team.

Bubs Australia has appointed Joe Coote as its new CEO, bringing extensive international FMCG and dairy leadership to spearhead its global growth ambitions in infant nutrition.

Adrad Holdings has appointed Paul Proctor as interim CEO following Kevin Boyle's resignation, while maintaining a steady earnings forecast for FY25.

ClearVue Technologies has appointed Douglas Hunt as its permanent Global CEO, unveiling a refreshed leadership team focused on scaling sales, manufacturing, and product innovation. The new executives have agreed to sub-market pay until the share price hits 35 cents, signaling strong alignment with shareholder interests.

NeuroScientific Biopharmaceuticals has appointed Nathan Smith as CEO, leveraging his deep cell therapy expertise to accelerate clinical development and commercialisation of its StemSmart technology.

WiseTech Global has appointed Zubin Appoo as its permanent CEO, succeeding interim leader Andrew Cartledge who will retire later this year. Appoo’s deep company roots and broad tech leadership experience position him to steer WiseTech’s next chapter.